• What we currently define for prostate RT is a ‘CTV’
• Level 1 evidence for shaping target volumes
• 3D shaping permits CFRT and IMRT
• Boosting the DIL remains under investigation as are Focal
Therapy strategies. Best assessed within appropriate trials.
• To maintain the therapeutic ratio, it is important to identify
BOTH the CTV and all OAR appropriately
Take Home Message




